E2B Code Validation

The following table lists the E2B Code Validation items.

Tag Name	DTD Element	Case Form Field	LM Field
primarysourcecountry	A.1.1	Case Form / General / Reporter Information / Country	LM / Countries / Code (A2)
occurcountry	A.1.2	Case Form / General / General Information / Country	LM / Countries / Code (A2)
reporttype	A.1.4	Case Form / General Information / Report Type	LM / Report Type / E2B Code
reportercountry	A.2.1.3	Case Form / General / Reporter Information / Country	LM / Countries / Code (A2)
qualification	A.2.1.4	Case Form / General / Reporter Information / Reporter Type	LM / Reporter Type / E2B Code
observestudytype	A.2.3.3	Case Form / General / Study Information / Observe Study Type	LM / Case Classification / E2B Code
sendertype	A.3.1.1	LM / Regulatory Authorities / Local Company Contact / Sender Type	LM / Regulatory Authorities / Local Company Contact / Sender Type
sendercountrycode	A.3.1.4e	LM / Regulatory Authorities / Local Company Contact / Country	LM / Countries / Code (A2)
receivertype	A.3.2.1	LM / Regulatory Authorities / Agency Information / Agency Type	LM / Regulatory Authorities / Agency Information / Agency Type
receivercountrycode	A.3.2.3e	LM / Regulatory Authorities / Agency Information / Contact Information / Country	LM / Countries / Code (A2)
patientonsetageunit	B.1.2.2b	Case Form / Patient / Patient Information / Age Units	LM / Age Units / E2B Code
patientagegroup	B.1.2.3	Case Form / Patient / Patient Information / Age Group	LM / Age Group / E2B Code
patientsex	B.1.5	Case Form / Patient / Patient Information / Gender	LM / Gender / E2B Code
parentageunit	B.1.10.2.2b	Case Form / Patient / Parent / Age Unit	LM / Age Units / E2B Code
parentsex	B.1.10.6	Case Form / Patient / Parent / Gender	LM / Gender / E2B Code
reactionoutcome	B.2.i.8	Case Form / Events / Event Information / Outcome of Event	LM / Event Outcome / E2B Code
testunit	B.3.1e	Case Form / Patient / Lab Data / Lab Data / Units	LM / Dossage Units / E2B Code
obtaindrugcountry	B.4.k.2.3	Case Form / Products / Product Information / Obtain Drug Country	LM / Countries / Code (A2)
drugauthorizationcountry	B.4.k.4.2	LM / Licenses / License Information / Country	LM / Countries / Code (A2)
drugstructuredosageunit	B.4.k.5.2	Case Form / Products / Dosage Regimens / Dose Units	LM / Dosage Unit / E2B Code
drugcumulativedosageunit	B.4.k.5.7	Case Form / Products / Total Dose to Primary Event	LM / Dosage Unit / E2B Code
drugadministrationroute	B.4.k.8	Case Form / Products / Dosage Regimens / Patient Route of Administration	LM / Routes of Administration / E2B Code
drugparadministration	B.4.k.9	Case Form / Products / Dosage Regimens / Parent Route of Administration	LM / Routes of Administration / E2B Code
drugintervaldosagedefinition	B.4.k.5.5	LM / Dosage Frequency / Unit	LM / Dosage Frequency / Unit
actiondrug	B.4.k.16	Case Form / Products / Product Details / Action Taken	LM / Action Taken / E2B Code
mhlwadmicsrcasenumclass	J.4a	Case Form / Analysis / PMDA / General / Report Category	LM / Reporting Category / E2B Code
mhlwadmicsrnewdrugclass	J.8	Case Form / Analysis / PMDA / Comments / Category of the new drug	LM / License Category / E2B Code
mhlwphaseofstudies	J.12.i.2	Business Configuration / Studies / Study Development Phase	LM / Study Development Phase / E2B Code